Matrix metalloproteinases in multiple sclerosis - Targets of therapy or markers of injury?

被引：16

作者：

Bever, CT

Rosenberg, GA

机构：

[1] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA

[2] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA

[3] VA Maryland Hlth Care Syst, Serv Neurol, Baltimore, MD USA

[4] VA Maryland Hlth Care Syst, Res Serv, Baltimore, MD USA

[5] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA

[6] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA

[7] Univ New Mexico, Sch Med, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA

来源：

NEUROLOGY | 1999年 / 53卷 / 07期

关键词：

D O I：

10.1212/WNL.53.7.1380

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1380 / 1381

页数：2

共 12 条

[1] GELATINASE IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH MULTIPLE-SCLEROSIS AND OTHER INFLAMMATORY NEUROLOGICAL DISORDERS [J].

GIJBELS, K ;

MASURE, S ;

CARTON, H ;

OPDENAKKER, G .

JOURNAL OF NEUROIMMUNOLOGY, 1992, 41 (01) :29-34

[2] Targets for the therapeutic action of interferon-beta in multiple sclerosis [J].

Hartung, HP ;

Kieseier, BC .

ANNALS OF NEUROLOGY, 1996, 40 (06) :825-826

[3] Matrix metalloproteinases in inflammatory demyelination - Targets for treatment [J].

Kieseier, BC ;

Seifert, T ;

Giovannoni, G ;

Hartung, HP .

NEUROLOGY, 1999, 53 (01) :20-25

[4] Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis [J].

Leppert, D ;

Waubant, E ;

Burk, MR ;

Oksenberg, JR ;

Hauser, SL .

ANNALS OF NEUROLOGY, 1996, 40 (06) :846-852

[5] Extracellular matrix degradation by metalloproteinases and central nervous system diseases [J].

Lukes, A ;

Mun-Bryce, S ;

Lukes, M ;

Rosenberg, GA .

MOLECULAR NEUROBIOLOGY, 1999, 19 (03) :267-284

[6] Effect of steroids on CSF matrix metalloproteinases in, multiple sclerosis: Relation to blood-brain barrier injury [J].

Rosenberg, GA ;

Dencoff, JE ;

Correa, N ;

Reiners, M ;

Ford, CC .

NEUROLOGY, 1996, 46 (06) :1626-1632

[7] TIMP-2 REDUCES PROTEOLYTIC OPENING OF BLOOD-BRAIN-BARRIER BY TYPE-IV COLLAGENASE [J].

ROSENBERG, GA ;

KORNFELD, M ;

ESTRADA, E ;

KELLEY, RO ;

LIOTTA, LA ;

STETLERSTEVENSON, WG .

BRAIN RESEARCH, 1992, 576 (02) :203-207

[8] Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: An expanded therapeutic window [J].

Rosenberg, GA ;

Estrada, EY ;

Dencoff, JE ;

StetlerStevenson, WG .

BRAIN RESEARCH, 1995, 703 (1-2) :151-155

[9]

StetlerStevenson WG, 1996, AM J PATHOL, V148, P1345

[10] Interferon beta-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9 [J].

Stuve, O ;

Dooley, NP ;

Uhm, JH ;

Antel, JP ;

Francis, GS ;

Williams, G ;

Yong, VW .

ANNALS OF NEUROLOGY, 1996, 40 (06) :853-863

← 1 2 →